Revolve Wealth Partners, LLC Amgen Inc Transaction History

Revolve Wealth Partners, LLC

$626 Million
Q3 2024

A detailed history of Revolve Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Revolve Wealth Partners, LLC holds 16,673 shares of AMGN stock, worth $4.38 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

16,673

Previous 16,948 1.62%

Holding current value

$4.38 Million

Previous $5.3 Million 1.45%

% of portfolio

0.86%

Previous 0.91%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $85,079 - $92,779	-275 Reduced 1.62%	16,673 $5.37 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $107,990 - $131,236	-411 Reduced 2.37%	16,948 $5.3 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $25,273 - $30,508	-94 Reduced 0.54%	17,359 $4.94 Million
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $511 - $576	2 Added 0.01%	17,453 $5.03 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $36,077 - $44,790	165 Added 0.95%	17,451 $4.69 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $9,642 - $11,401	45 Added 0.26%	17,286 $3.84 Million
Q1 2023 Apr 06, 2023	SELL	$225.79 - $275.2 $27,320 - $33,299	-121 Reduced 0.7%	17,241 $4.17 Million
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $370,112 - $470,272	-1,616 Reduced 8.52%	17,362 $0
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $15,487 - $17,467	69 Added 0.36%	18,978 $4.28 Million
Q2 2022 Jul 11, 2022	BUY	$230.71 - $256.74 $17,072 - $18,998	74 Added 0.39%	18,909 $4.6 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $2.12 Million - $2.35 Million	-9,689 Reduced 33.97%	18,835 $4.56 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $5.67 Million - $6.49 Million	28,524 New	28,524 $6.42 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Revolve Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Revolve Wealth Partners, LLC with notifications on news.

Account

Revolve Wealth Partners, LLC Amgen Inc Transaction History